3 completed. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow E-Cigarette: new trials by email Literature Review of E-Cigarette trials Research Report on E-Cigarette
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pulmonary and Cardiac Effects of E-Cigarette Use in Pulmonary Patients Who Smoke Cigarettes E-Cigarette, Financial Incentives - Chronic Obstructive Pulmonary Disease, Chronic Bronchitis | Phase 2 | Completed | University of Vermont | 21 | 2022-04-28 | 2024-02-08 |
| Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction Varenicline, e-cigarette - Smoking Cessation, Harm Reduction | Phase 2 / Phase 3 | Completed | Rose Research Center, LLC | 25 | 2019-11-19 | 2022-02-24 |
| Randomized Controlled Trial Methods for Novel Tobacco Products Evaluation e-cigarette, cigarette substitute - Nontherapeutic | Phase 1 / Phase 2 | Completed | Virginia Commonwealth University | 520 | 2015-06-01 | 2018-09-07 |
Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome (1) · Bronchitis, Chronic (1) · Emphysema (1) · Harm Reduction (1) · Pulmonary Disease, Chronic Obstructive (1) · Smoking Cessation (1) · Vaping (1)
Rose Research Center, LLC (1) · University of Vermont (1) · Virginia Commonwealth University (1)
United States (3)
Diann E Gaalema, PhD (1) · Thomas Eissenberg (1)
PMID 26941050, PMID 33857436, PMID 39142511, PMID 40533223
P50DA036105 (1), U54DA036114 (1)